Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes of Stockholders??? Equity (Deficit) (Unaudited)

v3.25.3
Condensed Consolidated Statements of Changes of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Total
Series B Preferred Stock
Conversion of notes payable to Common Stock
Conversion of Series A Preferred Stock to Common Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Conversion of Series A Preferred Stock to Common Stock
Series A Preferred Stock
Common Stock
Common Stock
Conversion of notes payable to Common Stock
Common Stock
Conversion of Series A Preferred Stock to Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series B Preferred Stock
Additional Paid-in Capital
Conversion of notes payable to Common Stock
Additional Paid-in Capital
Conversion of Series A Preferred Stock to Common Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2023         0 0   154,432                
Beginning Balance at Dec. 31, 2023 $ (41,786,850)       $ 0 $ 0   $ 15     $ 77,004,838       $ 0 $ (118,791,703)
Ending Balance (in shares) at Jun. 30, 2024         0 0   459,048                
Ending Balance at Jun. 30, 2024 (91,450,085)       $ 0 $ 0   $ 46     95,639,533       0 (187,089,664)
Beginning Balance (in shares) at Dec. 31, 2023         0 0   154,432                
Beginning Balance at Dec. 31, 2023 (41,786,850)       $ 0 $ 0   $ 15     77,004,838       0 (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Foreign currency translation adjustment (26,983)                           (26,983)  
Stock-based compensation 1,872,504                   1,872,504          
Reverse stock split round up and Adj (in shares)               14,887                
Reverse stock split round up and Adj 0             $ 1     (1)          
Vesting of RSUs (in shares)               11,033                
Vesting of RSUs 0             $ 1     (1)          
Exercise of warrants (in shares)               72,647                
Exercise of warrants 4,635,256             $ 7     4,635,249          
Conversion of convertible secured debentures (in shares)               216,839                
Conversion of convertible secured debentures 9,765,272             $ 22     9,765,250          
Issuance of Series B Preferred Stock and At the Market ("ATM") share offering (in shares)               156,270                
Issuance of Series B Preferred Stock and At the Market ("ATM") share offering 9,357,954             $ 16     9,357,938          
Net income (loss) (50,366,134)                             (50,366,134)
Ending Balance (in shares) at Sep. 30, 2024         0 0   626,108                
Ending Balance at Sep. 30, 2024 (66,548,981)       $ 0 $ 0   $ 62     102,635,777       (26,983) (169,157,837)
Beginning Balance (in shares) at Dec. 31, 2023         0 0   154,432                
Beginning Balance at Dec. 31, 2023 (41,786,850)       $ 0 $ 0   $ 15     77,004,838       0 (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Reverse stock split round up and Adj (in shares)               133,975                
Reverse stock split round up and Adj                     (13)          
Ending Balance (in shares) at Dec. 31, 2024         35,034     1,084,655                
Ending Balance at Dec. 31, 2024 (20,397,413)       $ 4     $ 108     233,343,056       (42,229) (253,698,352)
Beginning Balance (in shares) at Jun. 30, 2024         0 0   459,048                
Beginning Balance at Jun. 30, 2024 (91,450,085)       $ 0 $ 0   $ 46     95,639,533       0 (187,089,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Foreign currency translation adjustment (26,983)                           (26,983)  
Stock-based compensation 532,539                   532,539          
Reverse stock split round up and Adj (in shares)               14,887                
Reverse stock split round up and Adj 0             $ 1     (1)          
Vesting of RSUs (in shares)               968                
Vesting of RSUs 0                              
Exercise of warrants (in shares)               4,248                
Exercise of warrants 184,094                   184,094          
Conversion of convertible secured debentures (in shares)               146,957                
Conversion of convertible secured debentures 6,279,627             $ 15     6,279,612          
Net income (loss) 17,931,827                             17,931,827
Ending Balance (in shares) at Sep. 30, 2024         0 0   626,108                
Ending Balance at Sep. 30, 2024 (66,548,981)       $ 0 $ 0   $ 62     102,635,777       (26,983) (169,157,837)
Beginning Balance (in shares) at Dec. 31, 2024         35,034     1,084,655                
Beginning Balance at Dec. 31, 2024 (20,397,413)       $ 4     $ 108     233,343,056       (42,229) (253,698,352)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation 968,240                   968,240          
Reverse stock split round up and Adj (in shares)               64,144                
Reverse stock split round up and Adj 0             $ 6     (6)          
Vesting of RSUs (in shares)               36,995                
Vesting of RSUs 0             $ 4     (4)          
Conversion of convertible secured debentures (in shares)             (21,338)   200,600 3,100,383            
Conversion of convertible secured debentures 0   $ 2,870,573 $ 0     $ (3)   $ 20 $ 310     $ 2,870,553 $ (307)    
Issuance of Series B Preferred Stock and At the Market ("ATM") share offering (in shares)           3,000   1,938,353                
Issuance of Series B Preferred Stock and At the Market ("ATM") share offering 24,377,196 $ 2,855,000           $ 195     24,377,001 $ 2,855,000        
Earnout shares (contingent) 6,864,729                   6,864,729          
Other (in shares)               2,167                
Deemed dividend - Series A Down-round adjustment 0                   3,427,706         (3,427,706)
Net income (loss) (21,661,311)                             (21,661,311)
Ending Balance (in shares) at Sep. 30, 2025         13,696 3,000   6,427,297                
Ending Balance at Sep. 30, 2025 (4,122,986)       $ 1 $ 0   $ 643     274,705,968       (42,229) (278,787,369)
Beginning Balance (in shares) at Jun. 30, 2025         18,296 0   4,156,106                
Beginning Balance at Jun. 30, 2025 (5,675,340)       $ 2 $ 0   $ 416     263,086,186       (42,229) (268,719,715)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation 398,225                   398,225          
Reverse stock split round up and Adj (in shares)               64,144                
Reverse stock split round up and Adj 0             $ 6     (6)          
Vesting of RSUs (in shares)               18,555                
Vesting of RSUs 0             $ 2     (2)          
Conversion of convertible secured debentures (in shares)             (4,600)     1,082,231            
Conversion of convertible secured debentures       $ 0     $ (1)     $ 108       $ (107)    
Issuance of Series B Preferred Stock and At the Market ("ATM") share offering (in shares)           3,000   1,106,261                
Issuance of Series B Preferred Stock and At the Market ("ATM") share offering 4,939,077 $ 2,855,000           $ 111     4,938,966 $ 2,855,000        
Deemed dividend - Series A Down-round adjustment 0                   3,427,706         (3,427,706)
Net income (loss) (6,639,948)                             (6,639,948)
Ending Balance (in shares) at Sep. 30, 2025         13,696 3,000   6,427,297                
Ending Balance at Sep. 30, 2025 $ (4,122,986)       $ 1 $ 0   $ 643     $ 274,705,968       $ (42,229) $ (278,787,369)